Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

A Chicago woman who has struggled with Type 1 diabetes since childhood is now off insulin, thanks to doctors at the ...

Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Eknath Chavan, a 62-year-old man from Mumbai, celebrates his diabetes remission after 18 years, fitting into his wedding suit ...

Cinnamon is renowned for its ability to help regulate blood sugar. Creating a drink by infusing water with cinnamon sticks ...

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...